
Cross Berry Pharmaceuticals Private Limited
About Cross Berry Pharmaceuticals Private Limited
Data last updated:
Cross Berry Pharmaceuticals Private Limited is a private limited company based in Kolhapur, Maharashtra, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 13 February 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U33125PN2014PTC150609. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2.4 Lakh. It is led by directors Ashalata Deepak Wadakar and Deepak Anandarao Wadkar.
Its last annual general meeting (AGM) was held on 30 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at Kolhapur, Maharashtra.
As per the financials filed for FY 2020, the company reported a revenue of ₹69.6 Lakh, a growth of 50% compared to the previous year. For the same year it recorded a net profit of ₹41,276 (net margin 0.6%) and EBITDA of ₹2.39 Lakh (EBITDA margin 3.4%). Revenue has grown at a compounded annual rate (CAGR) of 40% over three years and 43% over five years.
As per MCA filings, the company has open charges of ₹20 Lakh and satisfied charges of ₹8 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Cross Berry Pharmaceuticals Private Limited's registered office is in Kolhapur, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address1016 Plot No 20 B Bhoite Nagar Near Dugadha Cooperative Housing Society Saneguruji, Vasahat, Kolhapur, Maharashtra, India – 416012
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Cross Berry Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Cross Berry Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Cross Berry Pharmaceuticals Private Limited, buy the company report.
Financials of Cross Berry Pharmaceuticals Private Limited
FY 2020 filings availableCross Berry Pharmaceuticals Private Limited reported revenue of ₹69.6 Lakh (up 50% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 43% over five years, including 50% growth in the latest year. EBITDA rose 157% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.39 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹41,276 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.4% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cross Berry Pharmaceuticals Private Limited, buy the company report.
Board of directors of Cross Berry Pharmaceuticals Private Limited
Cross Berry Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashalata Deepak Wadakar | Director | 25 Feb 2021 | 5 Years 8 Months | Current |
| Deepak Anandarao Wadkar | Director | 26 Jul 2019 | 7 Years 3 Months | Current |
Peer comparison
Cross Berry Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Hahnemann Pharmaceuticals Private Limited | ₹70.46 Lakh (FY 2024) | 28.0% | New Delhi, Delhi, India | |||
| Cross Berry Pharmaceuticals Private Limitedthis company | ₹69.6 Lakh (FY 2020) | ₹41,276 | 0.6% | 50.0% | Kolhapur, Maharashtra, India | |
| Deemar Pharmaceuticals Private Limited | ₹69.5 Lakh (FY 2025) | 46233.0% | Hyderabad, Telangana, India | |||
| Medcorpus Pharmaceuticals Private Limited | ₹69.28 Lakh (FY 2025) | 4.0% | Kolathur, Tamil Nadu, India |
To see the full peer comparison of Cross Berry Pharmaceuticals Private Limited, buy the company report.
Auditor
Cross Berry Pharmaceuticals Private Limited is audited by RAM S PATIL & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAM S PATIL & ASSOCIATES | FY 2017 | 135893 |
Shareholding
The shareholding of Cross Berry Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Cross Berry Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Jan 2022 | 100529723 | Others | ₹20 Lakh | Open | |
| 28 Dec 2017 | 100150910 | Bank of India | ₹8 Lakh | Satisfied |
To see the full charge records of Cross Berry Pharmaceuticals Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Cross Berry Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cross Berry Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Cross Berry Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Cross Berry Pharmaceuticals Private Limited, buy the company report.
Recent activity
Cross Berry Pharmaceuticals Private Limited has 6 board changes on record since 2019: 2 appointments and 4 cessations. The latest: Mohan Ramchandra Barage ceased to be Director on 26 Feb 2021.
Frequently asked questions
Cross Berry Pharmaceuticals is an active private limited company based in Kolhapur, Maharashtra, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 13 February 2014 (12+ years old) and is registered under CIN U33125PN2014PTC150609.
Cross Berry Pharmaceuticals has 2 current directors:
- Ashalata Deepak Wadakar - Director
- Deepak Anandarao Wadkar - Director
The latest financial statements of Cross Berry Pharmaceuticals on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 30 December 2020. Year-wise statements from 2015 are in the company report.
No. Cross Berry Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Cross Berry Pharmaceuticals is U33125PN2014PTC150609. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cross Berry Pharmaceuticals was incorporated on 13 February 2014, making it 12+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Cross Berry Pharmaceuticals by revenue are Hahnemann Pharmaceuticals Private Limited, Deemar Pharmaceuticals Private Limited, Medcorpus Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Mohan Ramchandra Barage ceased to be Director on 26 Feb 2021. Ashalata Deepak Wadakar was appointed as Director on 25 Feb 2021. Deepak Anandarao Wadkar ceased to be Additional Director on 30 Sep 2019. Cross Berry Pharmaceuticals has 6 board changes on record in total.
The registered office of Cross Berry Pharmaceuticals is at 1016 Plot No 20 B Bhoite Nagar Near Dugadha Cooperative Housing Society Saneguruji, Vasahat, Kolhapur, Maharashtra, India – 416012.
Cross Berry Pharmaceuticals operates in the chemicals industry, in the medicinal chemical and botanical products segment.
Cross Berry Pharmaceuticals has open charges of ₹20 Lakh and satisfied charges of ₹8 Lakh as per latest MCA filings.

